Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-005056

Chief Operating Officer sold 4,368 shares at $3.19 ($13,942)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bertrand William C JR Chief Operating Officer 2022-01-18 Sale −4,368 $3.19 $13,942 7,336 D
Open-market sales · 4,368 sh · avg $3.19 · $13,942
Loading xslF345X03/tm221700-18_4seq1.xml…